Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Organigram Global Inc.NASDAQ: OGI

Cash & Equivalents · Q2 FY2026 · quarter ended Mar 2026

Cash & equivalents rises 310.3% from a year ago

Cash & equivalents stood at CA$54.08M at the end of Q2 FY2026, up 310.3% from a year earlier and down 12.9% from the prior quarter.

Context

  • Cash & equivalents amounted to 10.3% of total assets at the end of Q2 FY2026, up 7.9 pp from a year earlier.
  • Cash & equivalents increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +310.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$54.08M-12.9% QoQ
Last fiscal yearSep 2025
CA$28.2M-73.6% YoY
Year agoMar 2025
CA$13.18M+310.3% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+310.3%——
1 year-73.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

CAD · from the balance sheet

Latest · FY2025
28.2M CAD
Year-over-year change
-73.6%
4-year CAGR
-15.5%

Cash & Equivalents vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +310.3% is the highest of 9, against a peer median of +20.3%.
  • Cash & equivalents amounts to 10.3% of total assets for OGI, versus a peer median of 28.2%.
OGI Competitors
Cash & Equivalents for OGI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
RNACCartesian Therapeutics, Inc.Mar 2026$118.64M USD-34.2%+5.5%41.1%
ACBAurora Cannabis Inc.Mar 2026CA$112.77M CAD-38.8%-27.9%18.7%
IVAInventiva S.A.Dec 2025€99.27M EUR+2.8%+4.6%39.9%
OGIOrganigram Global Inc.Mar 2026CA$54.08M CAD+310.3%—10.3%
OBIOOrchestra BioMed Holdings, Inc.Mar 2026$28.37M USD+54.6%+20.6%28.2%
DERMJourney Medical CorporationMar 2026$27.22M USD+29.2%-9.0%29.7%
LFCRLifecore Biomedical, Inc.Dec 2025$17.47M USD——7.5%
ELMDElectromed, Inc.Mar 2026$16.99M USD+11.5%+23.3%28.6%
HSDTSolana CompanyMar 2026$4.4M USD+296.3%-20.6%2.2%
INFUInfuSystem Holdings, Inc.Mar 2026$2.11M USD+39.8%+168.3%2.1%
Peer median (excluding OGI) —+20.3%+5.1%28.2%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Cash & Equivalents55.37M68.52M33.86M106.75M28.2M
Short-term Investments128.48M30.4M0821K826K
Net Receivables21M46.37M27.46M37.15M64.86M
Inventory48.82M68.28M80.95M82.52M123.95M
Other Current Assets5.51M2.21M13.7M25.86M55.39M
Total Current Assets260.62M221.62M155.98M262.22M284.9M
Property, Plant & Equipment (Net)235.94M259.82M99.05M96.23M122.98M
Goodwill14.32M41.98M0052.52M
Intangible Assets2.73M14.26M10.62M8.09M48.51M
Long-term Investments6.11M7.07M13.72M40.73M49.55M
Tax Assets3.2M0000
Other Non-current Assets31.11M32.36M19.09M591K3.75M
Total Non-current Assets293.4M355.48M142.48M145.64M277.31M
Total Assets554.02M577.11M298.46M407.86M562.21M
Account Payables18.95M40.86M14.73M47.1M89.25M
Short-term Debt80K80K76K60K25K
Tax Payables01.42M94K00
Deferred Revenue02.44M000
Other Current Liabilities6.25M12M2.35M5.14M35.91M
Total Current Liabilities26.27M55.29M22.43M53.32M126.16M
Long-term Debt230K155K3.63M25K0
Deferred Tax Liabilities03.62M000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities43.07M7.79M771K45.18M79.17M
Total Non-current Liabilities47.95M13.76M4.4M48.55M86.92M
Total Liabilities74.21M69.05M26.83M101.87M213.08M
Common Stock730.8M769.73M776.91M852.89M919.91M
Retained Earnings(275.64M)(289.93M)(538.53M)(583.97M)(608.73M)
Accumulated OCI24.65M28.26M33.25M37.07M37.95M
Other Stockholders Equity00000
Minority Interest00000
Total Equity479.81M508.06M271.62M305.99M349.13M
Total Debt5.95M3.36M3.71M4.46M8.75M
Net Debt(49.42M)(65.16M)(30.16M)(102.29M)(19.45M)

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.